MaxCyte (MXCT) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for June 18, 2025, at 11:00 a.m. Eastern Time.

• Shareholders are encouraged to vote electronically for convenience and promptness.

Voting matters and shareholder proposals

• Election of three Class I director nominees: Maher Masoud, Yasir Al-Wakeel, and Rekha Hemrajani.

• Amendment to the 2022 Equity Incentive Plan to increase shares issuable by 2,950,000.

• Proposal to cancel admission to trading of common stock on AIM, London Stock Exchange.

• Ratification of CohnReznick LLP as independent auditor for fiscal year ending December 31, 2025.

• Approval to adjourn the meeting if additional proxy solicitation is needed.

Board of directors and corporate governance

• Board recommends voting "FOR" all proposals and director nominees.

• Board leadership includes Fulford and David Sandoval as Senior Vice President, General Counsel, and Corporate Secretary.